Antimicrobial activity of camel milk casein and its hydrolysates

The aim of this study was to evaluate the antimicrobial activity of camel caseins and their hydrolysates by gastrointestinal proteolytic enzymes against 3 Gram-positive and 2 Gram-negative bacterial strains. Camel caseins (CN) were hydrolysed by successive action of pepsin and pancreatin. Hydrolysis of CN was checked by electrophoresis and gel filtration chromatography (GFC). Both techniques showed that CN was hydrolysed into peptides. Among the tested bacteria, a decrease of 19.3%±0.02 of E. coli XL1 blue cells growth was observed in the presence of undigested camel casein at a concentration of 20 mg ml−1. After successive hydrolyses by pepsin and pancreatin, camel milk casein hydrolysates still exhibited anti-bacterial activity against E. coli XL1 blue strain (19.73±0.01% growth inhibition under the same conditions). Gram-positive strain growth was not affected by intact camel CN, while, at the same concentration (20 mg ml–1), their hydrolysates slightly inhibited the growth of these bacteria. This suggests that antibacterial peptidic fragments of caseins were generated by pepsin and pancreatin

Crestar® and PMSG don't affect systemic insulin-like growth factor-I but induce oestrus in postpartum suckling dromedary females.

peer reviewe

Validation Of A Heterologous Radioimmunoassay For Insulin-Like Growth Factor-I In Camels

peer reviewe

Adjunctive everolimus therapy in tuberous sclerosis-associated refractory epilepsy

Presentation In this article we are reporting the beneficial impact of everolimus treatment on the renal & CNS manifestations of TSC. Diagnosis The patient diagnosed with refractory seizure associated with tuberous sclerosis. Treatment The patient was treated with everolimus, and he was commenced at a dose of 10 mg daily. Conclusion This report shows that everolimus treatment for three years of refractory seizures in patients with TSC, can lead to a clinically meaningful reduction in seizure frequency. Compared with other anti-epileptic medications, everolimus demonstrated additional benefits in reducing Subependymal giant cell astrocytoma (SEGA) and renal angiomyolipoma volume. At the time of preparation of this report, the patient continue treatment with daily everolimus without adverse events.</div

Radioimmunoassay measurement of insulin-like growth factor-I in camels: effects of anticoagulants and body condition score in suckling female.

peer reviewe

Effects of peripartum dietary supplements on productive/reproductive parameters, and plasma concentration of Insulin-like growth factor (IGF)-I in camels.

peer reviewe

Effects of peripartum dietary supplements on productive/reproductive parameters in plasma concentration of insulin-like growth factor (IGF)-I in camels.

peer reviewe